IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q4 FY22 results · Jan–Mar 2022
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹572.49 crore and net profit of ₹29.76 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 572.49 | — | — | — | — |
| Other income | 6.93 | — | — | — | — |
| Total income | 579.42 | — | — | — | — |
| Profit before tax | 38.71 | — | — | — | — |
| Net profit for the period | 29.76 | — | — | — | — |
| EPS, basic (₹) | 5.07 | — | — | — | — |
| Net margin (%) | 5.2 | — | — |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 572.49 | 460.38 | +24.4% | 555.14 | +3.1% |
| Other income | 6.93 | 6.21 | +11.6% | 8.88 | −22.0% |
| Total income | 579.42 | 466.59 | +24.2% | 564.02 | +2.7% |
| Profit before tax | 36.70 | 105.97 | −65.4% | 54.67 | −32.9% |
| Net profit for the period | 27.75 | 75.25 | −63.1% | 40.07 | −30.7% |
| EPS, basic (₹) | 4.73 | 12.76 | −62.9% | 6.82 | −30.6% |
| Net margin (%) | 4.8 | 16.3 | 7.2 |
Consolidated
- Filed with BSE
- 31 May 2022, 15:02 IST
- Board meeting
- 30 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 May 2022, 15:02 IST
- Board meeting
- 30 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE